Sodium Stibogluconate

Therapeutic Group

Agents Against Leishmaniasis

Indication Dosage

Sodium Stibogluconate is a medication primarily used for the treatment of visceral leishmaniasis, a tropical parasitic infection caused by protozoa of the Leishmania species. It is administered to patients to help combat and alleviate the symptoms associated with this serious and potentially life-threatening disease.

Visceral Leishmaniasis: 

By IV Inj, Or By IM Inj: 

  • Adult: 20 Mg/kg Daily For 28 Days 

Cutaneous Leishmaniasis: 

By IV Inj, Or By IM Inj: 

  • Adult: 20 Mg/kg Daily For 20 Days

Content

  • Inj: Per ml: Sodium Stibogluconate 100mg.

Pregnancy

Use Only If Potential Benefit Outweighs Risk.

Stability

  • Leishmaniacide

Contra Indications

  • None Known

Precautions

  • None Known

Lactation

  • Caution Advised

Side Effects

  • Abdominal Pain
  • Anorexia
  • Nausea
  • Vomiting
  • Pain On Injection Site
  • Diarrhoea
  • Ecg Changes
  • Cough
  • Headache
  • Lethargy
  • Arthralgia
  • Flushing Myalgia
  • Vertigo
  • Fever
  • Sweating
  • Rash
  • Pancreatitis
  • Anaphylaxis.
  • Rare: Bleeding From Gums And Nose
  • Jaundice
  • Substernal Pain
  • Sweating
  • Vertigo

Available Brands